Crinetics Pharmaceuticals Inc. anticipated last trading date Aug. 31, Nasdaq says

Crinetics Pharmaceuticals Inc. (CRNX) is expected to complete its final trading session on the Nasdaq on August 31, 2026, according to Nasdaq listings confirmation. This marks the anticipated last date on which the company’s common stock will be available for trading on the exchange. The move follows regulatory filings and procedures typically associated with delisting or transitioning from a publicly traded company to a private entity. Investors are advised to review the implications of this development, including potential liquidity constraints and the impact on portfolio diversification. No further details regarding the company’s future structure or operations have been disclosed in the referenced materials. As with any delisting event, market participants should remain informed through official communications from the company and regulatory bodies.